当前位置:首页 - 行情中心 - 瑞普生物(300119) - 财务分析

瑞普生物

(300119)

  

流通市值:73.89亿  总市值:102.52亿
流通股本:3.35亿   总股本:4.65亿

瑞普生物(300119)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润2.72亿元,每股收益0.56元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益509087.42万元,未分配利润190790.60万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产795498.09万元,负债286410.66万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入1,707,587,656.8821,616,475.93,069,933,116.781,746,806,365.21
营业总成本1,464,234,653.83694,874,920.332,690,140,421.731,466,821,630.31
其他经营收益
营业利润312,125,190.45137,340,410.3373,167,958.91304,079,230.76
利润总额311,509,253.46135,432,168.8368,289,124.91302,288,879.01
净利润272,063,586.89120,104,766.3329,833,903.18264,182,740.83
每股收益
其他综合收益----
综合收益总额272,063,586.89120,104,766.3329,833,903.18264,182,740.83
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计3,701,102,337.823,725,458,129.663,648,969,542.583,348,371,664.99
非流动资产:
非流动资产合计4,253,878,532.194,336,887,061.054,316,823,511.294,087,412,944.91
资产总计7,954,980,870.018,062,345,190.717,965,793,053.877,435,784,609.9
流动负债:
流动负债合计1,999,138,395.072,138,212,045.842,250,828,854.411,741,306,167.4
非流动负债:
非流动负债合计864,968,236.98840,596,233.41708,004,141.61736,630,765.67
负债合计2,864,106,632.052,978,808,279.252,958,832,996.022,477,936,933.07
所有者权益(或股东权益):
归属于母公司股东权益合计4,561,894,007.014,565,978,371.354,469,990,178.394,549,883,109.64
股东权益合计5,090,874,237.965,083,536,911.465,006,960,057.854,957,847,676.83
负债和股东权益合计7,954,980,870.018,062,345,190.717,965,793,053.877,435,784,609.9
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计1,935,001,493.84990,540,979.934,095,851,891.511,778,174,197.98
经营活动现金流出小计1,799,627,801.88917,009,839.793,360,305,684.361,422,050,640.26
经营活动产生的现金流量净额135,373,691.9673,531,140.14735,546,207.15356,123,557.72
投资活动产生的现金流量:
投资活动现金流入小计1,076,066,931.54660,680,833.823,536,719,552.462,604,449,087.07
投资活动现金流出小计1,074,938,614.84755,494,205.523,988,393,222.032,835,676,691.12
投资活动产生的现金流量净额1,128,316.7-94,813,371.7-451,673,669.57-231,227,604.05
筹资活动产生的现金流量:
筹资活动现金流入小计774,941,779.39264,701,382.411,073,222,252.25713,050,000
筹资活动现金流出小计854,950,006.69269,165,519.111,206,500,773.91823,448,004.05
筹资活动产生的现金流量净额-80,008,227.3-4,464,136.7-133,278,521.66-110,398,004.05
汇率变动对现金及现金等价物的影响172,814.38163,359.08664,007.64392,159.94
现金及现金等价物净增加额56,666,595.74-25,583,009.18151,258,023.5614,890,109.56
期末现金及现金等价物余额532,892,459.28450,642,854.36476,225,863.54336,420,024.26
补充资料:
现金及现金等价物的净增加额56,666,595.74-151,258,023.56-
最新报告期:2025-09-10
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
兴业证券潘江滢,纪宇泽0.981.181.402025-09-10
中信证券盛夏,彭家乐1.061.131.372025-09-01
国海证券熊子兴,程一胜0.991.191.352025-08-28
中邮证券王琦0.991.271.402025-08-27
中金公司王思洋,龙友琪0.871.04--2025-08-27
TOP↑